missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CD323 (JAM3) Monoclonal Antibody (CRAM-18 F26), FITC
Rat Monoclonal Antibody
Marque: Invitrogen™ MA528229
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
Rat anti Mouse JAM-c antibody, clone CRAM-18 F26 recognizes mouse and human Junctional adhesion molecule C (JAM-C), also known as JAM-3 and, historically, as JAM-2.
JAM3 is involved in tight junctions and represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. The protein encoded by this immunoglobulin superfamily gene member is localized in the tight junctions between high endothelial cells. Unlike other proteins in this family, the this protein is unable to adhere to leukocyte cell lines and only forms weak homotypic interactions. The encoded protein is a member of the junctional adhesion molecule protein family and acts as a receptor for another member of this family.
Spécification
| CD323 (JAM3) | |
| Monoclonal | |
| 0.1 mg/mL | |
| PBS with 1% BSA and 0.09% sodium azide | |
| Q9D8B7 | |
| JAM3 | |
| Recombinant soluble JAM-C. | |
| 100 μg | |
| Primary | |
| Mouse | |
| Antibody | |
| IgG2a |
| Flow Cytometry, Immunocytochemistry | |
| CRAM-18 F26 | |
| FITC | |
| JAM3 | |
| 1110002N23Rik; JAM-2; JAM3; JAM-3; JAMC; JAM-C; Jcam3; junction adhesion molecule 3; junction cell adhesion molecule 3; junction cell adhesion molecule C; junctional adhesion molecule 3; Junctional adhesion molecule C; sJAM-C; Soluble form of JAM-C; UNQ859/PRO1868 | |
| Rat | |
| Protein G | |
| RUO | |
| 83964 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. Store in the dark. | |
| Liquid |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu